Radioligand Therapy (RLT) Market worth $10.91 billion by 2035

added blog Health

2025-10-09 12:58:42 -

The report "Radioligand Therapy (RLT) Market by Product (Lutetium-177 Vipivotide Tetraxetan, (Lu-177)- PNT2002, Radium-223 dichloride), Target (PSMA, SSTR, Bone Metastases), Indication (Prostate Cancer, Neuroendocrine Tumors (NETS), SCLC) - Global Forecast to 2035", is projected to reach USD 10.91 billion by 2035 from USD 3.15 billion in 2025, at a CAGR of 13.2% during the forecast...

0 Comments 0 Shares 425 Views 0 Reviews